Your browser doesn't support javascript.
loading
Essential Oils and Neuropathic Pain.
Ridouh, Imane; Hackshaw, Kevin V.
Afiliación
  • Ridouh I; Dell Medical School, University of Texas, 1601 Trinity St., Austin, TX 78712, USA.
  • Hackshaw KV; Dell Medical School, University of Texas, 1601 Trinity St., Austin, TX 78712, USA.
Plants (Basel) ; 11(14)2022 Jul 07.
Article en En | MEDLINE | ID: mdl-35890431
Neuropathic pain is one of the most prominent chronic pain syndromes, affecting almost 10% of the United States population. While there are a variety of established pharmacologic and non-pharmacologic treatment options, including tricyclic antidepressants (TCAs), serotonin-noradrenaline reuptake inhibitors, anticonvulsants, trigger point injections, and spinal cord stimulators, many patients continue to have chronic pain or suboptimal symptom control. This has led to an increased interest in alternative solutions for neuropathic pain such as nutritional supplements and essential oils. In this review, we explore the literature on the most commonly cited essential oils, including lavender, bergamot, rosemary, nutmeg, Billy goat weed, and eucalyptus. However, the literature is limited and largely comprised of preclinical animal models and a few experimental studies, some of which were poorly designed and did not clearly isolate the effects of the essential oil treatment. Additionally, no standardized method of dosing or route of administration has been established. Further randomized control studies isolating the active components of various essential oils are needed to provide conclusive evidence on the use of essential oils for neuropathic pain. In this review, we explore the basis behind some of the essential oils of interest to patients with neuropathic pain seen in rheumatology clinics.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Plants (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Plants (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos